Table 2.
CAMARADES characteristics of included animal studies
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Parsa et al. [98] | √ | √ | √ | X | √ | √ | √ | X | √ | √ | 8/10 |
| Shekarchian et al. [99] | √ | √ | √ | X | X | √ | √ | X | X | √ | 6/10 |
| Jesmin et al. [100] | √ | √ | √ | X | X | √ | √ | X | X | √ | 6/10 |
| Lang et al. [101] | √ | √ | √ | √ | √ | √ | √ | X | √ | √ | 9/10 |
| Shima et al. [102] | √ | √ | √ | X | X | √ | √ | X | √ | √ | 7/10 |
| Shima et al. [103] | √ | √ | X | X | X | √ | √ | X | √ | √ | 6/10 |
√ = fulfilled, X = not fulfilled, 1 = Published in peer-reviewed journal, 2 = Control of temperature, 3 = Randomisation, 4 = Allocation concealed, 5 = Blinding of assessors, 6 = No anaesthetics with marked intrinsic properties, 7 = Use of animals with diabetes, 8 = Sample size calculation, 9 = Compliance with regulatory requirements, 10 = Statement regarding conflict of interest